- Home
- Publications
- Publication Search
- Publication Details
Title
IGF-IR Targeted Therapy: Past, Present and Future
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-12-24
DOI
10.3389/fendo.2014.00224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can we unlock the potential of IGF-1R inhibition in cancer therapy?
- (2014) Helen King et al. CANCER TREATMENT REVIEWS
- Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
- (2014) Roberta Malaguarnera et al. ENDOCRINOLOGY
- Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment
- (2014) Sandra Heskamp et al. MOLECULAR IMAGING AND BIOLOGY
- Drug resistance to targeted therapies: Déjà vu all over again
- (2014) Floris H. Groenendijk et al. Molecular Oncology
- Theranostic applications of antibodies in oncology
- (2014) Emmy D.G. Fleuren et al. Molecular Oncology
- Insulin-Like Growth Factor 1 Receptor (IGF-1R) as a Target of MiR-497 and Plasma IGF-1R Levels Associated with TNM Stage of Pancreatic Cancer
- (2014) Jian-Wei Xu et al. PLoS One
- Insulin Analogs and Cancer: A Note of Caution
- (2014) Joseph A. M. J. L. Janssen et al. Frontiers in Endocrinology
- Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells
- (2014) Doron Weinstein et al. Endocrine Connections
- Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
- (2013) Leonard Girnita et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Chronic Insulin Exposure does not Cause Insulin Resistance but is Associated with Chemo-resistance in Colon Cancer Cells
- (2013) I. Baricevic et al. HORMONE AND METABOLIC RESEARCH
- Growth hormone and cancer
- (2013) Jo K. Perry et al. Current Opinion in Endocrinology Diabetes and Obesity
- IGF-1R as an anti-cancer target--trials and tribulations
- (2013) Helen X. Chen et al. Chinese Journal of Cancer
- Targeting the insulin-like growth factor-1 receptor in human cancer
- (2013) Alexandre Arcaro Frontiers in Pharmacology
- Insulin and its analogues and their affinities for the IGF1 receptor
- (2012) Aimee J Varewijck et al. ENDOCRINE-RELATED CANCER
- Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
- (2012) Irène Asmane et al. EUROPEAN JOURNAL OF CANCER
- The decline and fall of the IGF-I receptor
- (2012) Renato Baserga JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling
- (2012) Aimee J. Varewijck et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer
- (2012) N. Awasthi et al. MOLECULAR CANCER THERAPEUTICS
- Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
- (2012) Jun Gyu Kim et al. PLoS One
- Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
- (2011) E. D. G. Fleuren et al. CLINICAL CANCER RESEARCH
- A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2011) F. Atzori et al. CLINICAL CANCER RESEARCH
- Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody
- (2011) D. H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
- (2011) Erin R. King et al. Recent Patents on Anti-Cancer Drug Discovery
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
- (2009) J. Veeken et al. CURRENT CANCER DRUG TARGETS
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
- (2009) Daniel D. Karp et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- IGF2: Epigenetic regulation and role in development and disease
- (2008) Wendy Chao et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
- (2008) Marta Guix et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation